Posted in | News | Graphene

Applied Graphene Materials plc Announce Joint Development Agreement with Puralube Germany GmbH

Applied Graphene Materials plc, the producer of specialty graphene materials, is pleased to announce that the Group has entered into a Joint Development Agreement with Puralube Germany GmbH (shortly to be known as "Puraglobe"), a German based lubricants and oils business that  has developed technologies to refine used lubricants and oils.

Puraglobe's products are sold to a global customer base for use in applications such as motor oils, hydraulic oils, automatic transmission fluids, process oils, metal working fluids and industrial oils.

Under the Joint Development Agreement, Applied Graphene Materials will develop and format dispersions of its graphene nanoplatelets for inclusion in Puraglobe's sustainable base oil products and speciality technologies.

It is anticipated that as result of the collaboration, Puraglobe's graphene loaded base oils will be used across a wide range of industrial and automotive applications, where the unique friction and wear properties of graphene will add significant performance gains as lubricants and machining fluids.

Applied Graphene Materials and Puraglobe are in discussions with several companies seeking to improve the performance of a range of machinery whilst also looking to deliver reduced environmental impact and lower CO2 output through the use of Puraglobe's sustainable products.

The Joint Development Agreement with Puraglobe is the second direct Joint Development Agreement where the Group has been permitted to name its commercial counterparty, following on from the announcement in September, of the Group's collaboration with Millers Oils.

As previously reported, the pace and momentum of commercial progress has continued to accelerate. Applied Graphene Materials is engaged with a large number of customers, many of them leaders in their market, where the exact nature of activities remains confidential due to commercial sensitivity.

This includes a recent Joint Development Agreement with a European speciality polymers and composites business with niche development activity across the aerospace, automotive and leisure industries.

The Group's collaboration partner wishes to preserve confidentiality at this stage, however the agreement is particularly focused on finding early adoption opportunities for graphene nanoplatelets where the material's multi-functionality offers clear benefits.

Typical of the properties the collaboration will look to exploit are mechanical toughening, thermal and electrical conductivity as well as enhanced fire resistance.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Applied Graphene Materials. (2019, February 11). Applied Graphene Materials plc Announce Joint Development Agreement with Puralube Germany GmbH. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=34015.

  • MLA

    Applied Graphene Materials. "Applied Graphene Materials plc Announce Joint Development Agreement with Puralube Germany GmbH". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=34015>.

  • Chicago

    Applied Graphene Materials. "Applied Graphene Materials plc Announce Joint Development Agreement with Puralube Germany GmbH". AZoNano. https://www.azonano.com/news.aspx?newsID=34015. (accessed November 21, 2024).

  • Harvard

    Applied Graphene Materials. 2019. Applied Graphene Materials plc Announce Joint Development Agreement with Puralube Germany GmbH. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=34015.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.